Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1722507

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1722507

Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2025-2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global narcolepsy drugs market size reached USD 3.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.64% during 2025-2033. The increasing awareness and diagnosis of narcolepsy, growing prevalence of sleep disorders, ongoing advancements in drug development, and favorable regulatory environment are primarily driving the market's growth.

Narcolepsy drugs refer to pharmaceutical medicines used for the treatment of chronic sleep disorders. The disorder is characterized by excessive daytime sleepiness (EDS), cataplexy or sudden loss of muscle strength, sleep paralysis, hallucinations, fragmented sleep and insomnia. Additional symptoms may include automatic behaviors without conscious awareness, blurred vision, double vision or droopy eyelids and disturbed mental functioning. Patients suffering from narcolepsy tend to sleep the same number of hours per day as normal individuals; however, sleep quality tends to be poorer. Some of the commonly used narcolepsy drugs include central nervous system stimulants, sodium oxybate, selective serotonin reuptake inhibitors and tricyclic antidepressants. These drugs aid in improving wakefulness in adult patients and minimizing hallucinations, sleepiness and cataplexy.

Narcolepsy Drugs Market Trends:

The increasing prevalence of narcolepsy across the globe is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the working population, which, in turn, is significantly increasing the incidences of sleep-related disorders. Moreover, rising health consciousness among the masses and the increasing awareness regarding the available treatment alternatives are providing a thrust to the market growth. In line with this, the widespread adoption of sodium oxybate for the treatment of narcolepsy in children is also contributing to the growth of the market. Additionally, significant improvements in the diagnostic technologies for narcolepsy are acting as other growth-inducing factors. Pharmaceutical manufacturers are also developing variants with long-term benefits and reduced side effects. Other factors, including the rising geriatric population, which is more susceptible to such ailments, along with extensive research and development (R&D) activities in the field of neurology, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Type:

  • Narcolepsy with Cataplexy
  • Narcolepsy without Cataplexy
  • Secondary Narcolepsy

Breakup by Disease Type:

  • Daytime Extreme Sleepiness
  • Cataplexia
  • Others

Breakup by Therapeutic Type:

  • Sodium Oxybate
  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Selective Serotonin Reuptake Inhibitor
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1.How big is the narcolepsy drugs market?
  • 2.What is the future outlook of narcolepsy drugs market?
  • 3.What are the key factors driving the narcolepsy drugs market?
  • 4.Which region accounts for the largest narcolepsy drugs market share?
  • 5.Which are the leading companies in the global narcolepsy drugs market?
Product Code: SR112025A5685

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Narcolepsy Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Narcolepsy with Cataplexy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Narcolepsy without Cataplexy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Secondary Narcolepsy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Disease Type

  • 7.1 Daytime Extreme Sleepiness
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cataplexia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Therapeutic Type

  • 8.1 Sodium Oxybate
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Central Nervous System Stimulants
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Tricyclic Antidepressants
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Selective Serotonin Reuptake Inhibitor
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Avadel Pharmaceuticals plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Axsome Therapeutics Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Bioprojet Pharma
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Graymark Healthcare Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Jazz Pharmaceuticals plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Ligand Pharmaceuticals Incorporated
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 SHIONOGI & Co. Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Takeda Pharmaceutical Company Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teva Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
Product Code: SR112025A5685

List of Figures

  • Figure 1: Global: Narcolepsy Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Narcolepsy Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Narcolepsy Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Narcolepsy Drugs Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Narcolepsy Drugs Market: Breakup by Disease Type (in %), 2024
  • Figure 6: Global: Narcolepsy Drugs Market: Breakup by Therapeutic Type (in %), 2024
  • Figure 7: Global: Narcolepsy Drugs Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Narcolepsy Drugs (Cataplexia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Narcolepsy Drugs (Cataplexia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Narcolepsy Drugs (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Narcolepsy Drugs (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Narcolepsy Drugs (Sodium Oxybate) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Narcolepsy Drugs (Sodium Oxybate) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Narcolepsy Drugs (Other Therapeutic Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Narcolepsy Drugs (Other Therapeutic Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Narcolepsy Drugs Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Narcolepsy Drugs Industry: SWOT Analysis
  • Figure 80: Global: Narcolepsy Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Narcolepsy Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Narcolepsy Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Narcolepsy Drugs Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Narcolepsy Drugs Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
  • Table 4: Global: Narcolepsy Drugs Market Forecast: Breakup by Therapeutic Type (in Million USD), 2025-2033
  • Table 5: Global: Narcolepsy Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Narcolepsy Drugs Market: Competitive Structure
  • Table 7: Global: Narcolepsy Drugs Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!